Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Comparing different types of PRP injections for treating tennis elbow

Official title: Leukocyte-rich PRP or Leukocyte-free PRP vs Placebo in the Treatment of Epicondylitis: a Randomized Controlled Clinical Trial

Run by Istituto Ortopedico Rizzoli · NCT06040203 · Data updated 2026-11-12

This study is testing whether two different types of PRP injections can help people with tennis elbow who haven't found relief from other treatments.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment240 (estimated)
SponsorIstituto Ortopedico Rizzoli
Academic / other
Locations1 site (Bologna)
StatusRecruiting
StartedMarch 23, 2023
Main results expectedMarch 2027
Study endsMarch 2027
Registry record updatedSeptember 29, 2025
Trial IDNCT06040203 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 65 with chronic epicondylitis symptoms lasting over three months who have not benefited from conservative treatments.

Probably not a fit

Patients who have undergone previous surgical treatment on the elbow tendons or recent injections in the past six months may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The EPIC-PRP study is a double-blind randomized controlled trial designed to evaluate the effectiveness of echo-guided injections of leukocyte-rich platelet-rich plasma (LR-PRP) and leukocyte-poor platelet-rich plasma (LP-PRP) compared to a saline placebo in patients with tennis elbow who have not responded to conservative treatments. Participants will be randomly assigned to one of three groups and will receive a single injection, followed by clinical evaluations at multiple time points to assess improvement and any adverse events. The study aims to provide insights into the safety and efficacy of these injection techniques for managing chronic elbow pain.

Why it matters

Potential benefit: If successful, this study could offer a more effective treatment option for patients suffering from chronic tennis elbow.

How similar studies have gone: Previous studies have shown promising results with PRP injections for various musculoskeletal conditions, suggesting potential success for this approach in treating epicondylitis.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients with epicondylitis of the elbow:

1. Patients with clinical picture of epicondylitis;
2. Duration of symptoms \> 3 months
3. Ultrasound picture of short or long radial extensor carpal tendinopathy;
4. Age \> 18 and \< 65
5. Both sexes;
6. Failure, defined as persistence of symptoms, of other conservative treatments for at least 3 months;
7. Hemoglobin \> 11 g/dl;
8. Platelet count \> 150,000 plt/mm3 (Recently performed CBC examination);
9. Negative serological tests for HBsAg, HCV Ab, HIV-1-2 Ab
10. No clinically significant electrocardiographic changes (Recently performed ECG);
11. Ability and consent of the patient to actively participate in clinical follow-up;
12. Signature of informed consent.

Exclusion Criteria:

1. Patients undergoing previous surgical treatment on the epicondylar tendons;
2. Patients undergoing epicondylar infiltration in the previous 6 months;
3. Inability of patients to actively participate in clinical follow-up;
4. Incapacitated patients;
5. Patients with states of immunodepression;
6. Patients with fibromyalgia;
7. Ongoing systemic inflammatory diseases (stabilized outcomes of such diseases are not considered absolute contraindications);
8. Patients with uncontrolled thyroid metabolic disorders;
9. Patients abusing alcoholic beverages, drugs or medications;
10. Patients who have taken NSAIDs in the 3 days prior to blood collection;
11. Patients with coagulation problems or with ongoing antiplatelet therapy that cannot be suspended for at least 3 days prior to blood draw;
12. Patients with cardiovascular disease for whom a 300-mL blood draw would be contraindicated;
13. Positive serological tests for HBsAg, HCV Ab, HIV-1-2 Ab
14. Other current elbow diseases (osteoarthritis, prevalence of symptomatology due to epitrochleitis, stiff elbow, etc.)

Where it's running

  • Istituto Ortopedico Rizzoli
    Bologna, Italy
    Recruiting

Study contacts

  • Principal investigator: Enrico Guerra, MD — Istituto Ortopedico Rizzoli - SC Chirurgia della spalla e del gomito
  • Study coordinator: Enrico Guerra, MD
  • Email: enrico.guerra@ior.it
  • Phone: 0516366567

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.